Publications by authors named "Robbert van der Most"

Claim this Profile
S
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.
Mario Cortese, Thomas Hagan, Nadine Rouphael, Sheng-Yang Wu, Xia Xie, Robbert van der Most

Nat Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and persistent responses after H5N1 vaccination in humans.
Richard Apps, Angélique Biancotto, Julián Candia, Yuri Kotliarov, Shira Perl, Robbert G van der Most

Cell Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine.
Viviane Bechtold, Kinga K Smolen, Wivine Burny, Simone P de Angelis, Simon Delandre, Robbert van der Most

Sci Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
Adam Zuiani, Charles L Dulberger, Nilushi S De Silva, Meghan Marquette, Yu-Jung Lu, Robbert van der Most

Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design.
Carolin Loos, Margherita Coccia, Arnaud M Didierlaurent, Ahmed Essaghir, Jonathan K Fallon, Robbert van der Most

NPJ Vaccines· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: "World in motion" - emulsion adjuvants rising to meet the pandemic challenges.
Derek T O'Hagan, Robbert van der Most, Rushit N Lodaya, Margherita Coccia, Giuseppe Lofano

NPJ Vaccines· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
Sofia M Buonocore, Robbert G van der Most

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Robbert Van Der Most

NPJ Vaccines· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
Margherita Coccia, Wivine Burny, Marie-Ange Demoitié, Paul Gillard, Robert A van den Berg, Robbert van der Most

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19.
Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Robbert Van Der Most

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.
Prabhu S Arunachalam, Yupeng Feng, Usama Ashraf, Mengyun Hu, Alexandra C Walls, Robbert Van Der Most

Sci Transl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults.
Katia J Bruxvoort, Bradley Ackerson, Lina S Sy, Amit Bhavsar, Hung Fu Tseng, Robbert Van Der Most

J Infect Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.
Lilit Grigoryan, Audrey Lee, Alexandra C Walls, Lilin Lai, Benjamin Franco, Robbert van der Most

NPJ Vaccines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination.
Stephane Carryn, Brigitte Cheuvart, Michael Povey, Alemnew F Dagnew, Rafael Harpaz, Robbert van der Most

J Infect Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate.
Stephen C De Rosa, Kristen W Cohen, Matthew Bonaparte, Bo Fu, Sanjay Garg, Robbert Van der Most

Clin Transl Immunology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"World in motion" - emulsion adjuvants rising to meet the pandemic challenges.
Derek T O'Hagan, Robbert van der Most, Rushit N Lodaya, Margherita Coccia, Giuseppe Lofano

NPJ Vaccines· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Alexandra C Walls, Marcos C Miranda, Alexandra Schäfer, Minh N Pham, Allison Greaney, Robbert Van Der Most

Cell· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.
Joseph R Francica, Barbara J Flynn, Kathryn E Foulds, Amy T Noe, Anne P Werner, Robbert van der Most

Sci Transl Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.
Florian Wimmers, Michele Donato, Alex Kuo, Tal Ashuach, Shakti Gupta, Robbert van der Most

Cell· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination as a preventative measure contributing to immune fitness.
Béatrice Laupèze, Giuseppe Del Giudice, Mark T Doherty, Robbert Van der Most

NPJ Vaccines· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Prabhu S Arunachalam, Alexandra C Walls, Nadia Golden, Caroline Atyeo, Stephanie Fischinger, Robbert Van Der Most

Nature· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants.
Sonia Budroni, Francesca Buricchi, Andrea Cavallone, Patricia Bourguignon, Magalie Caubet, Robbert van der Most

NPJ Vaccines· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.
Joseph R Francica, Barbara J Flynn, Kathryn E Foulds, Amy T Noe, Anne P Werner, Robbert van der Most

bioRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Alexandra C Walls, Marcos C Miranda, Minh N Pham, Alexandra Schäfer, Allison Greaney, Robbert Van Der Most

bioRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.
Prabhu S Arunachalam, Alexandra C Walls, Nadia Golden, Caroline Atyeo, Stephanie Fischinger, Robbert Van Der Most

bioRxiv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis